CTKB Cytek Biosciences, Inc.
$6.14▲ +2.68%
Healthcare
Other
After hours
$6.05▼ -1.47%
Oct 28, 5:41 PM ET
Volume 1.60M
Avg Volume (10D) 947.2K
Key Metrics & Fundamentals
Market Cap
$798.10M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.31 - 6.32
% vs 50 MA
17.70%
% vs 200 MA
32.13%
RSI-14
69.6
MACD Histogram
+0.0500
Beta (1Y vs SPY)
0.87
Free Cash Flow
-$877,000
Gross Rev
$48.14M
Gross Profit
$28.34M
EBITDA
-$8.38M
COGS
$19.80M
Operating Exp
$39.74M
Operating Income
-$11.40M
EBIT
-$11.40M
Pretax Income
-$11.64M
Net Income
-$12.16M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
Zacks · Oct 28, 2026 9:00 AM ET
Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh Profitability
Simply Wall St. · Oct 24, 2026 8:14 PM ET
Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire · Oct 21, 2026 4:05 PM ET
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability
Insider Monkey · Sep 29, 2026 10:14 AM ET
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
GlobeNewswire · Sep 23, 2026 5:00 PM ET
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?
Zacks · Sep 17, 2026 8:48 AM ET
Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows
MT Newswires · Sep 9, 2026 9:52 AM ET
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
GlobeNewswire · Sep 9, 2026 8:30 AM ET
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing
Insider Monkey · Sep 9, 2026 2:37 AM ET
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
GlobeNewswire · Sep 3, 2026 5:00 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CTKB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.